Clinical trial shows biomarkers hold clue in treating aggressive prostate cancer

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup